Galmed Pharmaceuticals (GLMD) Other Non Operating Income (2013 - 2023)

Galmed Pharmaceuticals' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $13000.0 for Q1 2023.

• In Q1 2023, Other Non Operating Income rose 750.0% year-over-year to $13000.0; the TTM figure through Mar 2023 stood at $833000.0 (changed 0.36% YoY), while the FY2025 annual figure was $741000.0, up 43.6% from the prior year.
• Other Non Operating Income was $13000.0 for Q1 2023 at Galmed Pharmaceuticals, up from -$2000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $532000.0 in Q2 2019 to a low of -$2000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $208250.0 across 4 years, with a median of $151500.0 in 2020.
• The sharpest annual moves came in 2020 and 2023: Other Non Operating Income slumped 45.49% in 2020, then surged 750.0% in 2023.
• A 4-year view of Other Non Operating Income shows it stood at $532000.0 in 2019, then plunged by 45.49% to $290000.0 in 2020, then tumbled by 100.69% to -$2000.0 in 2022, then soared by 750.0% to $13000.0 in 2023.
• The last three Other Non Operating Income figures came in at $13000.0 (Q1 2023), -$2000.0 (Q1 2022), and $290000.0 (Q2 2020), per Business Quant data.